Reading and Resources

Aggarwal R, Ringold S, Khanna D, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken). 2015;67:891-897.

Braun J. Axial spondyloarthritis including ankylosing spondylitis. Rheumatology (Oxford). 2018;57(suppl 6):vi1-vi3.

Cheung PP. Anti-IL17A in axial spondyloarthritis—where are we at? Front Med (Lausanne). 2017;4:1.

Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. J Clin Rheumatol. 2019;38:625-634.

Dubash S, McGonagle D, Marzo-Ortega H. New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice. Ther Adv Chronic Dis. 2018;9:77-87.

Dubreuil M, Deodhar AA. Axial spondyloarthritis classification criteria: the debate continues. Curr Opin Rheumatol. 2017;29:317-322.

Magrey M, Ritchlin C. Measuring outcomes in ankylosing spondylitis: pearls and pitfalls. Curr Opin Rheumatol. 2019;31:109-117.

Marzo-Ortega H, Gaffney KM, Gaffney K. Defining the target: clinical aims in axial spondyloarthritis. Rheumatology (Oxford). 2018;57(suppl 6):vi18-vi22.

Noureldin B, Barkham N. The current standard of care and the unmet needs for axial spondyloarthritis. Rheumatology (Oxford). 2018;57(suppl 6):vi10-vi17.

Paine A, Ritchlin CT. Targeting the interleukin-23/17 axis in axial spondyloarthritis. Curr Opin Rheumatol. 2016;28:359-367.

Proft F, Poddubnyy D. Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria. Ther Adv Musculoskelet Dis. 2018;10:129-139.

Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777-783.

Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390:73-84.

Strand V, Singh JA. Patient burden of axial spondyloarthritis. J Clin Rheumatol. 2017;23:383-391.

Terenzi R, Monti S, Tesei G, Carli L. One year in review 2017: spondyloarthritis. Clin Exp Rheumatol. 2018;36:1-14.

Torgutalp M, Poddubnyy D. IL-17 inhibition in axial spondyloarthritis: current and future perspectives. Expert Opin Biol Ther. 2019;19:631-641.

van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978-991.

Wang R, Ward MM. Epidemiology of axial spondyloarthritis: an update. Curr Opin Rheumatol. 2018;30:137-143.

Ward MM, Deodhar A, Akl EA, et al. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2016;68:282-298.


Patient Education

CreakyJoints. Raising the Voice of Patients: A Patient’s Guide to Living with Ankylosing Spondylitis.

Spondylitis Association of America.

Yu D, van Tubergen A. Patient education: Axial spondyloarthritis, including ankylosing spondylitis (Beyond the Basics).


Clinical Trials

NIH US National Library of Medicine.


Professional Organizations

American College of Rheumatology.


National Institute of Arthritis and Musculoskeletal and Skin Diseases.

National Library of Medicine.

Spondylitis Association of America.

Spondyloarthritis Research and Treatment Network.

The Arthritis Foundation.

Scroll to Top